In spite of the wide individual variance, mean levels of FZD7 were significantly up-regulated in the CML patients, compared with the normal controls (p = 0.012) (Supplementary Figure S4). Here, FZD7 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.